Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction

Completed · Phase 1 · Has a placebo group

Conditions studied: Myocardial Infarction

In brief

The purpose of the study is to determine whether adult stem cells \[Provacel™(PUMP1)\] are safe and possibly effective in the treatment of acute myocardial infarction (heart attack).

Key facts

Study ID
NCT00114452
Run by
Mesoblast, Inc.
People needed
60
Starts
2005-03-22
Expected to finish
2008-04-24
Last updated by the study team
2020-03-10

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.